HTGM - HTG Molecular Diagnostics Inc. (HTGM) CEO John Lubniewski on Q1 2022 Results - Earnings Call Transcript
HTG Molecular Diagnostics, Inc. (HTGM) Q1 2022 Earnings Conference Call May 12, 2022, 16:30 ET Company Participants Monique Kosse - LifeSci Advisors John Lubniewski - President, CEO & Director Shaun McMeans - SVP, CFO, Secretary & Treasurer Conference Call Participants Dipesh Patel - H.C. Wainwright Presentation Operator Thank you for standing by. This is the conference operator. Welcome to the HTG Molecular Diagnostics, Inc. First Quarter 2022 Earnings Call. As a reminder, the conference is being recorded. [Operator Instructions]. I would now like to turn the conference over to Ms. Monique Kosse with LifeSci Advisors. Please go ahead. Monique Kosse Thank you, operator. Before we begin the call, let me remind you that the company's remarks include forward-looking statements within the meaning of the federal securities laws, including statements regarding our expected revenue build and momentum in 2022, our expectations regarding profiling revenue in future periods, our expectation that customers
For further details see:
HTG Molecular Diagnostics, Inc. (HTGM) CEO John Lubniewski on Q1 2022 Results - Earnings Call Transcript